ClinicalTrials.gov
ClinicalTrials.gov Menu

Docetaxel - Carboplatin as Second Line Treatment in Patients With Small Cell Lung Cancer (DOCAR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00686985
Recruitment Status : Unknown
Verified May 2008 by Jeroen Bosch Ziekenhuis.
Recruitment status was:  Recruiting
First Posted : May 30, 2008
Last Update Posted : May 30, 2008
Sponsor:
Information provided by:
Jeroen Bosch Ziekenhuis

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Estimated Study Completion Date : July 2010